Lumos Pharma

$14.83
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.14 (-0.94%) As of 4:56 PM UTC today

Why Robinhood?

You can buy or sell Lumos Pharma and other stocks, options, and ETFs commission-free!

About LUMO

Lumos Pharma, Inc. Common Stock, also called Lumos Pharma, is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of therapeutics for rare diseases. Its product includes LUM-201, an oral growth hormone stimulating small molecule for the treatment of pediatric growth hormone deficiency (PGHD). The company was founded on June 4, 1999 and is headquartered in Austin, TX. The listed name for LUMO is Lumos Pharma, Inc. Common Stock.

CEO
Richard J. Hawkins
Employees
21
Headquarters
Austin, Texas
Founded
1999
Market Cap
129.68M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
32.03K
High Today
$15.11
Low Today
$14.50
Open Price
$14.68
Volume
8.38K
52 Week High
$36.72
52 Week Low
$6.74

LUMO Earnings

-$0.86
-$0.50
-$0.15
$0.21
Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Estimated
-$0.86 per share
Actual
Available Mar 9, After Hours

You May Also Like

MDLY
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure